TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 39 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $32,000 | -40.7% | 71,968 | -9.1% | 0.02% | -41.2% |
| Q2 2019 | $54,000 | -50.0% | 79,198 | 0.0% | 0.03% | -54.1% |
| Q1 2019 | $108,000 | +116.0% | 79,198 | 0.0% | 0.07% | +89.7% |
| Q4 2018 | $50,000 | -69.1% | 79,198 | 0.0% | 0.04% | -63.6% |
| Q3 2018 | $162,000 | -24.3% | 79,198 | 0.0% | 0.11% | -33.1% |
| Q2 2018 | $214,000 | +16.9% | 79,198 | 0.0% | 0.16% | -17.1% |
| Q1 2018 | $183,000 | -58.0% | 79,198 | -39.2% | 0.19% | -58.0% |
| Q4 2017 | $436,000 | – | 130,204 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 995,000 | $3,134,000 | 0.33% |
| NEA Management Company, LLC | 2,759,217 | $8,692,000 | 0.30% |
| Eventide Asset Management | 900,000 | $2,835,000 | 0.16% |
| QVT Financial LP | 308,227 | $916,000 | 0.03% |
| Candriam S.C.A. | 143,000 | $450,000 | 0.01% |
| Virtu Financial LLC | 23,684 | $75,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 13,352 | $42,000 | 0.00% |
| BLUESTEIN R H & CO LLC | 16,000 | $50,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 54,135 | $171,000 | 0.00% |
| Alyeska Investment Group, L.P. | 97,676 | $308,000 | 0.00% |